Depressive symptoms during and after radiotherapy for head and neck cancer

Head and Neck

Volumn 25, Issue 12, 2003, Pages 1004-1018

  Sehlen, Susanne ^a   Lenk, Marcus ^a   Herschbach, Peter ^b   Aydemir, Uelker ^a   Dellian, Marc ^a   Schymura, Beatrice ^a   Hollenhorst, Helmuth ^a   Dühmke, Eckhart ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Depression; Head and neck cancer; Psychooncology; Quality of life; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; COGNITION; CONTROLLED STUDY; DEPRESSION; EDUCATION; FEMALE; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCREENING; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PSYCHOLOGICAL TESTS; RADIOTHERAPY; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 0344851766     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10336     Document Type: Article

References (36)

1. Kugaya A, Akechi T, Okuyama T, et al. Prevalence, predictive factors, and screening for psychological distress in patients with newly diagnosed head and neck cancer. Cancer 2000;88:2817-2823.
2. Derogatis L, Morrow GR, Fetting JH, Penman D, Piasetsky S, Schmale AH. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751-757.
3. Hammerlid E, Bjordal K, Ahlner-Elmqvist M, et al. Prospective, longitudinal quality-of-life study of patients with head and neck cancer: a feasibility study including the EORTC QLQ-C30. Otolaryngol Head Neck Surg 1997; 116:666-673.
4. Duffy SA, Terrell JE, Valenstein M, Ronis DL, Copeland LA, Connors M. Effect of smoking, alcohol and depression on the quality of life of head and neck cancer patients. Gen Hosp Psychiatry 2002;24:140-147.
5. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol 1999;35:27-32.
6. Hammerlid E, Hammerlid E, Ahlner-Elmqvist M, Bjordal K, et al. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 1999;80: 766-774.
7. de Leeuw JR, de Graeff A, Ros WJ, Blijham G, Hordijk GJ, Winnubst JA. Prediction of depression 6 months to 3 years after treatment of head and neck cancer. Head Neck 2001;23:892-898.
8. Passik SD, Dugan W, McDonald MV, et al. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998,16:1594-1600.
9. Tennen H, Affleck G, Allen D, McGrade B, Ratzsan S. Causal attributions and coping with insulin-dependent diabetes. Basic Appl Soc Psychol 1984;46:489-502.
10. Malcrane V, Compas BE, Howell D. Cognitive factors in adjustment to cancer: Attributions of self-blame and perceptions of control. J Behav Med 1995;18:401-418.
11. Christensen AJ, Moran PJ, Ehlers SL, Raichle K, Karnell L, Funk G. Smoking and drinking behaviour in patients with head and neck cancer: effects of behavioural self-blame and perceived control. J Behav Med 1999;22: 407-418.
12. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 1999;46:437-443.
13. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
14. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
15. Zung W. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.
16. Zung W, King RE. Identification and treatment of masked depression in a general medical practice. J Clin Psychiatry 1983;44:365-368.
17. Dugan W. Use of the Zung self-rating depression scale in cancer patients: feasibility as a screening tool. Psycho Oncology 1998;7:483-493.
18. Zung W. Zung Self-Rating Depression Scale and Depression Status Inventory. In: Satorius N, Ban T, editors. Assessment of depression. New York: Springer Verlag; 1986. p 221-213.
19. Passik SD, Lundberg JC, Rosenfeld B, et al. Factor analysis of the Zung Self-Rating Depression Scale in a large ambulatory oncology sample. Psychosomatics 2000;41: 121-127.
20. Barefoot J, Brummett BH, Helms MJ, Mark DB, Siegler IC, Williams RB. Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med 2000;62:790-795.
21. Sakamoto S, Kijima N, Tomoda A, Kambara M. Factor structures of the Zung self-rating Depression Scale (SDS) for Undergraduates. J Clin Psychol 1998;54:477-487.
22. Köhle K, Simons C, Kubanek B. Zum Umgang mit unheilbar Kranken. In: Üxküll T, Adler RH, Hermann JM, Köhle K, Schonecke OW, Wesiack W, editors. Psychosomatische Medizin. München, Wien, Baltimore: Urban & Schwarzenberg; 1996. p 1224-1249.
23. Zung WWK. Review of placebo-controlled trials with bupropion. J Clin Psychiatry 1983;44(5, sec 2):104-114.
24. Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: Mac Leod E, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p 191-205.
25. Kollbrunner J, Zbaeren P, Quack K. Lebensqualitätsbelastung von Patienten mit groBen Tumoren der Mundhöhle. Eine deskriptive Studie der psychosozialen Auswirkungen von Krankheit und primär chirurgischer Therapie in 3 Teilen-Teil 1: Quantität und Qualität des Lebens. HNO 2001;49:985-997.
26. Filipp SH, Aymanns P. Bewältigungsstrategien (Coping). In: Üxküll T, Adler RH, Herrmann J, Köhle K, Schonecke OW, Wesiack W, editors. Psychosomatische Medizin. München, Wien, Baltimore: Urban & Schwarzenberg; 1996. p 277-290.
27. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
28. Bentzen SM, Saunders MI, Dische S, Bond SJ. Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 2001;60:123-135.
29. Magne N, Marcy PY, Chamorey E, et al. Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis. Head Neck 2001;23:678-682.
30. Skladowski K, Maciejewski B, Golden M, Pilecki B, Przeorek W, Tarnawski R. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumor control and normal tissue toxicity. Radiother Oncol 2000;55:101-110.
31. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001;23:389-398.
32. Condon JT. The 'unresearched' - those who decline to participate. Aust N Z J Psychiatry 1986;20:87-89.
33. Franz M, Schmepank H, Wirth T, Schellberg D. Die Teilnahmeverweigerung von Probanden in einer epidemiologischen Langzeitstudie - soziodemografisch, klinische und psychometrische Befunde. Psychother. Psychosom Med Psychol 1992;42:392-399.
34. Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies - quality of life issues. Cancer 2002;94: 1131-1141.
35. Kugaya A, Akechi T, Okamura H, et al. Correlates of depressed mood in ambulatory head and neck cancer patients. Psycho-Oncology 1999;8:494-499.
36. Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y. Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study. Cancer 2001;92:2609-2622.